Your browser doesn't support javascript.
loading
Dynamic 68Ga-DOTA0-Tyr3-octreotate positron emission tomography-computed tomography for the evaluation of pancreatic neuroendocrine tumors: a pilot study.
Yin, Hongyan; Liu, Guobing; Tan, Hui; Shi, Dai; Cheng, Dengfeng; Yu, Haojun; Shi, Hongcheng.
Affiliation
  • Yin H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liu G; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tan H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shi D; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Cheng D; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yu H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shi H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Quant Imaging Med Surg ; 13(9): 5555-5567, 2023 Sep 01.
Article in En | MEDLINE | ID: mdl-37711843
ABSTRACT

Background:

68Ga-DOTA0-Tyr3-octreotate (68Ga-DOTATATE) is a radiolabeled somatostatin analog used for the diagnosis of pancreatic neuroendocrine tumors (pNETs), and standardized uptake value (SUV) measurements for therapeutic monitoring is recommended. However, changes in net influx rate (Ki) may better reflect treatment effects than may those of the SUV. The aim of this study was to investigate the value of dynamic 68Ga-DOTATATE positron emission tomography-computed tomography (PET-CT) in the evaluation of pNETs.

Methods:

Dynamic PET-CT scans over 60 min were acquired for 7 patients with localized pancreatic mass before surgery. Maximal and mean SUV (SUVmax and SUVmean) were measured in tumors and normal pancreatic body as reference tissue (RT). Time-activity curves (TACs) were extracted from tumors and RT. A 2-tissue compartment model was used to calculate the rate constants K1, k2, and k3 (min-1); Ki (mL/g/min); and K1k2 ratio. The following statistical tests were used to evaluate the

results:

the Shapiro-Wilk, Student t test, Mann-Whitney, Spearman, and Pearson rank correlation tests.

Results:

Among 6 patients, 8 primary tumors were histopathologically proven to be pNETs. Moreover, 6 lesions with high uptake of 68Ga-DOTATATE showed an ascending TAC pattern, while 2 lesions with no or low uptake showed a descending TAC pattern. The mean SUVmax and SUVmean of pNETs were 46.4±40.2 (range, 3.9-109.9) and 21.9±16.0 (range, 0.5-42.8), respectively, which were significantly higher than the SUVmax of 4.2±0.6 (range, 3.1-4.9) and the SUVmean of 2.7±1.0 (range, 1.4-3.6) for the RT (P=0.021 and P=0.036), respectively. The Ki of pNETs was statistically higher than that of the RT [pNET 0.366±0.372 (range, 0.019-0.992); RT 0.060±0.017 (range, 0.04-0.08); P=0.036]. The mean K1k2 ratio in pNETs was 12-fold higher than that of RT (6.06 vs. 0.50). In pNETs, there was a positive correlation between SUVmax and Ki (r=0.952; P<0.001) and between SUVmean and Ki (r=0.905; P=0.002). Another patient was diagnosed with intrapancreatic accessory spleen.

Conclusions:

The uptake of 68Ga-DOTATATE by pNETs can be explained by its high Ki value and K1k2 ratio. Dynamic 68Ga-DOTATATE PET-CT can serve as a potential tool for evaluating pNETs and support the further assessment of a larger cohort of patients.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Quant Imaging Med Surg Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Quant Imaging Med Surg Year: 2023 Document type: Article Affiliation country: China